{"disease":{"id":"albinism-ocular","name":"albinism ocular"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04495218","title":"NGS Panel of Incomplete Forms of Ocular Albinism","phase":"","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06345976","title":"Functional Impairment in Albinism","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT03959605","title":"Genetic Determinant of Foveolar Hypoplasia in Parents of Albinos Children","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}